TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF

In certain aspects, the present disclosure relates to TβRII fusion polypeptides comprising a heterologous portion and a truncated, ligand-binding portion of the extracellular domain of TβRII polypeptide useful to selectively antagonize a TβRII ligand. The disclosure further provides compositions and...

Full description

Saved in:
Bibliographic Details
Main Authors SAKO, Dianne S, KUMAR, Ravindra
Format Patent
LanguageEnglish
French
German
Published 01.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In certain aspects, the present disclosure relates to TβRII fusion polypeptides comprising a heterologous portion and a truncated, ligand-binding portion of the extracellular domain of TβRII polypeptide useful to selectively antagonize a TβRII ligand. The disclosure further provides compositions and methods for use in treating or preventing TGFβ associated disorders.
AbstractList In certain aspects, the present disclosure relates to TβRII fusion polypeptides comprising a heterologous portion and a truncated, ligand-binding portion of the extracellular domain of TβRII polypeptide useful to selectively antagonize a TβRII ligand. The disclosure further provides compositions and methods for use in treating or preventing TGFβ associated disorders.
Author SAKO, Dianne S
KUMAR, Ravindra
Author_xml – fullname: SAKO, Dianne S
– fullname: KUMAR, Ravindra
BookMark eNrjYmDJy89L5WSwCnF303VyDXFUCHJ1dg0I8Q9SCIkMcFXw9FRwCw329PdTCAjyD3H19AtWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASZGJoYWJhaOxsZEKAEAX2cqUw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PROTÉINES DE FUSION DU RÉCEPTEUR TGF-BÊTA DE TYPE II ET UTILISATIONS ASSOCIÉES
FUSIONSPROTEINE VOM TGF-BETA-REZEPTOR TYP II UND VERWENDUNGEN DAVON
ExternalDocumentID EP4241848A3
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4241848A33
IEDL.DBID EVB
IngestDate Fri Aug 23 07:04:58 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4241848A33
Notes Application Number: EP20230171804
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&CC=EP&NR=4241848A3
ParticipantIDs epo_espacenet_EP4241848A3
PublicationCentury 2000
PublicationDate 20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 20231101
  day: 01
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Acceleron Pharma Inc
RelatedCompanies_xml – name: Acceleron Pharma Inc
Score 3.4961936
Snippet In certain aspects, the present disclosure relates to TβRII fusion polypeptides comprising a heterologous portion and a truncated, ligand-binding portion of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&locale=&CC=EP&NR=4241848A3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1DedivOLPEjfimKythOKrG1qJ2wtJZX5NJoshb10w1X8-17rNn3RtyOB43LkvnIfAbjNC0WlbSlTyqJvMueemrKnHVPOFOvrHHVlk8Efja0oYy-T3qQF800vTDMn9LMZjogSpVDeq0ZfL38esYKmtnJ1J-e4tHgKhRsY6-gYnRW8YkbguTyJg9g3fB8hY5y6DC2Vw5wB3YFd9KLtuvqLv3p1U8ryt0UJj2AvQWRldQwtXXbgwN98vNaB_dE6343gWvRWJ_AonkPT42JAUu7zRMQpEW8JJ8MhCbNaI5IkjQXHYJwMxgHJUE8SEfGUx-EpkJALPzKRiOn2wFOebMmlZ9AuF6U-B8IUo5oWuZUryYreg1PYuSwotWsvQ0nZhe6faC7-2buEw5pz3w12V9Cu3j_0NVraSt40PPoC7QF-CQ
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsX5mQfpW1FM1nbCkK1N7XRrQ8lkPo0mtrCXbriK_77Xuk1f9C0kcFyO3O_ucrkLwHWSaapsS5tKZR2TObfUVO3UMdWbZp00QaysMvij0ArG7GnSntRgtq6FqfqEflbNEVGjNOp7UeH14ucSy6veVi5v1Ayn5g--7HrGKjpGZwWPmOH1u1xEXuQarosjI4y7DC2Vw5we3YJt9LCdss0-f-mXRSmL3xbF34cdgcTy4gBqad6Ehrv-eK0Ju6NVvhuHK9VbHsK9fPTNPpc9EnOXCxnFRL4KTgYD4o9LRCQijiTHYJz0Qo-MESeJDHjMI_8IiM-lG5jIxHSz4SkXG3bpMdTzeZ6eAGGa0ZRmiZVoxbL2nZPZicootUsvQyvVgtafZE7_WbuCRiBHw-lwED6fwV4pxe9iu3OoF-8f6QVa3UJdVvL6Av49gPk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TGF-BETA+RECEPTOR+TYPE+II+FUSION+PROTEINS+AND+USES+THEREOF&rft.inventor=SAKO%2C+Dianne+S&rft.inventor=KUMAR%2C+Ravindra&rft.date=2023-11-01&rft.externalDBID=A3&rft.externalDocID=EP4241848A3